These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23241062)

  • 21. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease.
    Wang D; Li X; Gao K; Lu D; Zhang X; Ma C; Ye F; Zhang L
    Pharmacol Biochem Behav; 2013 Jun; 107():48-57. PubMed ID: 23541490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
    J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D; Liu X; Liu Y; Li S; Wang C
    J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.
    Wang Y; Tang XC; Zhang HY
    J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
    Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
    Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM; Inestrosa NC
    Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
    Frye CA; Walf AA
    Neurobiol Learn Mem; 2008 Jan; 89(1):17-26. PubMed ID: 17988898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
    Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G
    Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
    Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
    J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.
    Lee S; Lemere CA; Frost JL; Shea TB
    J Alzheimers Dis; 2012; 28(2):423-31. PubMed ID: 22045486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent disruption in hippocampal θ oscillation in amyloid-β overproducing transgenic mice.
    Scott L; Feng J; Kiss T; Needle E; Atchison K; Kawabe TT; Milici AJ; Hajós-Korcsok E; Riddell D; Hajós M
    Neurobiol Aging; 2012 Jul; 33(7):1481.e13-23. PubMed ID: 22227005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
    Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
    Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP; Brown RE
    Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease.
    Zerbi V; Jansen D; Wiesmann M; Fang X; Broersen LM; Veltien A; Heerschap A; Kiliaan AJ
    Neurobiol Aging; 2014 Mar; 35(3):600-13. PubMed ID: 24210253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.